Hi I am coming up to year 6 on the Flair trial, on the ibrutinib and rituximab arm.
Ibrutinib has worked very well for me with none of the major side effects, but many irritating minor side effects.
I am moving to the Static trial where I will be off or on ibrutinib through choice or randomisation.
All patients on ibrutinib can choose to stay on it and still enter the trial on the on ibrutinib arm.
This is my dilemma do I stick with what I know works for me or do I go and take the 50% risk of being allocated to the off ibrutinib arm.
There are pros and cons to both arms of the trial. On ibrutinib can over time lead to resistance, but may not!! Off ibrutinib could reduce resistance or may not. This is the purpose of the trial to see if drug holidays reduce the risks of ibrutinib resistance.
I feel blessed to have been on the Flair trial and finding a drug that worked for me, first time around.
I feel doubly blessed on entering the Static trial where I will be part of learning about how ibrutinib would be best administered in the future.
I am pleased to have a choice but just don’t know which choice to make.
If there are others out there trying to make the same choice, have already made it, or are already on the trial I would appreciate their views and experiences.
Ann